Mittie Doyle - Net Worth and Insider Trading
Mittie Doyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mittie Doyle owns 1 companies in total, including DICE Therapeutics Inc (DICE) .
Click here to see the complete history of Mittie Doyle’s form 4 insider trades.
Insider Ownership Summary of Mittie Doyle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DICE | DICE Therapeutics Inc | 2022-03-24 | director |
Mittie Doyle Trading Performance
Mittie Doyle Ownership Network
Ownership Network List of Mittie Doyle
Ownership Network Relation of Mittie Doyle
Mittie Doyle Owned Company Details
What does DICE Therapeutics Inc do?
Who are the key executives at DICE Therapeutics Inc?
Mittie Doyle is the director of DICE Therapeutics Inc. Other key executives at DICE Therapeutics Inc include 10 percent owner Northpond Ventures Gp, Llc , CSO John R. Jacobsen , and director & CEO Kevin Judice .
DICE Therapeutics Inc (DICE) Insider Trades Summary
Over the past 18 months, Mittie Doyle made no insider transaction in DICE Therapeutics Inc (DICE). Other recent insider transactions involving DICE Therapeutics Inc (DICE) include a net sale of 37,509 shares made by John R. Jacobsen , a net purchase of 1,007,701 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 2,492,871 shares made by Northpond Ventures Gp, Llc .
In summary, during the past 3 months, insiders sold 0 shares of DICE Therapeutics Inc (DICE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,666,925 shares of DICE Therapeutics Inc (DICE) were sold and 1,007,701 shares were bought by its insiders, resulting in a net sale of 1,659,224 shares.
DICE Therapeutics Inc (DICE)'s detailed insider trading history can be found in Insider Trading Tracker table.
DICE Therapeutics Inc Insider Transactions
Mittie Doyle Mailing Address
Above is the net worth, insider trading, and ownership report for Mittie Doyle. You might contact Mittie Doyle via mailing address: C/o Dice Therapeutics, Inc., 279 E. Grand Avenue, Suite 300, Lobby B, South San Francisco Ca 94080.